All News
Filter News
Found 808,979 articles
-
Weill Cornell Medical College Scientists Discover How to Shutdown Cancer's Powerful Master Protein
3/4/2013
-
Gluten-Free Beer? Common Gluten Detection Method is Inaccurate, Commonwealth Scientific and Industrial Research Organization Study
3/4/2013
-
Rise-N-Shine, LLC: New Pill Promises to Permanently Cure Gray Hair
3/4/2013
-
University of California, San Diego (UCSD) Researchers Create Virtual Map of Human Metabolism in Health and Disease
3/4/2013
-
Albert Einstein College of Medicine Scientists Identify "Clean-Up" Snafu That Kills Brain Cells in Parkinson's Disease
3/4/2013
-
"Shelf Life" of Blood? Shorter Than We Think, Johns Hopkins University School of Medicine Study
3/4/2013
-
URL Pharma May no Longer be Cash Cow in Philadelphia
3/4/2013
-
GlaxoSmithKline DMD Drug Tied to Serious Side Effects, Hospitalizations
3/4/2013
-
Two New Genes Linked to Amyotrophic Lateral Sclerosis (ALS) and Related Disorders, St. Jude Children's Research Hospital Study
3/4/2013
-
First Evidence That Obesity Gene is Risk Factor for Melanoma, University of Leeds Study
3/4/2013
-
Sinopharm Group Buys 57% of Winteam Pharma for $252 Million
3/4/2013
-
OrthoAccel Technologies, Inc. Receives Clearance to Sell AcceleDent in Canada - Delivers First Order This Week
3/4/2013
-
Vertex Pharmaceuticals (MA) Nails Mid-Stage Study for Influenza
3/4/2013
-
Life Technologies Signs License and Collaborative Stem Cell Research Agreement With Harvard University
3/4/2013
-
Regeneron Pharmaceuticals, Inc. Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments
3/4/2013
-
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection® in Argentina
3/4/2013
-
Elan Corporation PLC to Pay Shareholders Tysabri Dividends in Challenge to Bid
3/4/2013
-
Pharma Tech Industries Selected to Manufacture Innovative Nasal Delivery System for NDA Submission
3/4/2013
-
FDA Accepts Biogen Idec, Inc. (Massachusetts)'s Biologics License Application for First Long-Lasting Factor IX Therapy for Hemophilia B
3/4/2013
-
Iroko Pharmaceuticals Announces Acceptance for NDA Filing of Lower Dose Submicron Diclofenac for the Treatment of Mild to Moderate Acute Pain in Adults
3/4/2013